Coinfection
ICAAC 2012: Raltegravir Shows Long-term Safety and Efficacy for HIV/HCV and HIV/HBV Coinfection
- Details
- Category: HIV/Hepatitis Coinfection
- Published on Thursday, 20 September 2012 00:00
- Written by Liz Highleyman
The HIV integrase inhibitor raltegravir (Isentress) was well-tolerated and demonstrated continued effectiveness for 5 years in treatment-naive and 3 years in treatment-experienced HIV patients coinfected with hepatitis B or C, according to a poster presentation at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) last week in San Francisco.
ICAAC 2012: HCV Polymerase Inhibitor Sofosbuvir Appears Safe and Effective for HIV/HCV Coinfected People
- Details
- Category: HCV Treatment
- Published on Wednesday, 12 September 2012 00:00
- Written by Liz Highleyman
HIV/
HCV coinfected people taking the experimental hepatitis C virus (HCV) polymerase inhibitor sofosbuvir (formerly GS-7977) experienced a rapid decline in HCV viral load similar to that seen in HIV negative patients, researchers reported this week at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) in San Francisco. Side effects were also similar, and there was no sign of interactions with antiretroviral drugs in this 14-day study
AIDS 2012: Is Sexually Transmitted Hepatitis C among HIV+ Gay Men Leveling Off in Amsterdam?
- Details
- Category: HIV/HCV Coinfection
- Published on Friday, 03 August 2012 00:00
- Written by Liz Highleyman
The decade-long outbreak of sexually transmitted hepatitis C virus (HCV) infection among HIV positive men who have sex with men in Amsterdam appears to have leveled off since 2007, perhaps due to increased testing and treatment, but more education and screening are needed, researchers reported at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC 
Coverage of the 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, cancer caused by HPV, influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section
Coverage of the XIX International AIDS Conference
- Details
- Category: HIV Treatment
- Published on Friday, 27 July 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the XIX International AIDS Conference (AIDS 2012), July 22-27 in Washington, DC.
Conference highlights include experimental antiretroviral drugs, treatment as prevention and PrEP, scaling up HIV treatment and prevention in resource-limited countries, human rights and concerns of heavily impacted populations, AIDS policy and advocacy, HIV/HBV and HIV/HCV coinfection, and the search for a cure for HIV.
HIVandHepatitis.com AIDS 2012 conference section
7/27/12
Coverage of 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy -- better known as ICAAC -- in San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, and cancer caused by HPV, along with a gamut of other infectious diseases including influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section
9/11/12
AIDS 2012: HIV/HCV Coinfected People at Greater Risk for Liver Decompensation
- Details
- Category: HIV/HCV Coinfection
- Published on Thursday, 26 July 2012 00:00
- Written by Liz Highleyman
Despite effective antiretroviral therapy (ART), people coinfected with HIV and hepatitis C remain at higher risk for decompensated liver disease and other liver-related complications than those with hepatitis C alone, according to findings presented this week at the XIX International AIDS Conference (AIDS 2012) in Washington, DC.
AIDS 2012: Rapid Liver Disease in HIV+ Men with Acute HCV: The Debate Continues
- Details
- Category: HIV/HCV Coinfection
- Published on Thursday, 16 August 2012 00:00
- Written by Liz Highleyman
Gay and bisexual men who are already HIV positive when they become infected with hepatitis C virus (HCV) may experience unusually rapid and severe liver disease progression, according to a presentation by Daniel Fierer at the XIX International AIDS Conference (AIDS 2012) last month in Washington, DC. Other experts, however, disagree with this conclusion.
Hepatitis C Raises Risk of Both Liver-Related and Non-Liver Deaths
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 24 July 2012 00:00
- Written by Liz Highleyman
Overall mortality from both liver-related disease and non-liver conditions -- including some cancers -- is significantly increased in people with chronic hepatitis C virus (HCV) infection compared with uninfected individuals, according to a study published in the July 17, 2012, advance online edition of the Journal of Infectious Diseases.
Web Design and Development by